DRUG UTILIZATION EVALUATION IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS - Amrohi, Dr. Nazia Lateef;Begum, Dr. Husaini;Latha, Dr. Madhavi
26,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
13 °P sammeln
  • Broschiertes Buch

The aim of the present work was to study the treatment pattern in the patients diagnosed with chronic obstructive pulmonary disease. The total number of drugs the patient received during their treatment period 19.20% of antibiotics are given to the patients , 18.70% of Corticosteroids , 18.10% of Short acting beta -2 agonist , 17.20% of Inhaled corticosteroids , 15.50% Methyxanthines , 6.90% of Systemic corticosteroids, 4.10% of Long acting beta -2 agonist , 0.30% of Secretolytic agents. According to route of administration the percentage was calculated as 23.70% of oral administrated drug, 37.98% are parenterally administered, 38.32% are inhalations.…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
The aim of the present work was to study the treatment pattern in the patients diagnosed with chronic obstructive pulmonary disease. The total number of drugs the patient received during their treatment period 19.20% of antibiotics are given to the patients , 18.70% of Corticosteroids , 18.10% of Short acting beta -2 agonist , 17.20% of Inhaled corticosteroids , 15.50% Methyxanthines , 6.90% of Systemic corticosteroids, 4.10% of Long acting beta -2 agonist , 0.30% of Secretolytic agents. According to route of administration the percentage was calculated as 23.70% of oral administrated drug, 37.98% are parenterally administered, 38.32% are inhalations.
Autorenporträt
I La Dra. Nazia Lateef Amrohi, trabaja como profesora asistente en el Departamento de Práctica Farmacéutica Clínica, Sree Dattha Institute of Pharmacy, Afiliado a JNTUH, Acreditado por la NBA, Sheriguda, Ibrahimpatnam, Hyderabad, Telangana, 501510